Immunoassay for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide in human plasma.
Heart failure (HF) is complex clinical symptoms of lesion of myocardial structure and function, caused by myocardial infarction, cardiomyopathy, hypertension, inflammation and so on. The main manifestations are dyspnea, weakness and fluid retention, eventually leading to lowering the ventricular pumping and filling function. N-terminal pro B-type natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) are recommended indicators of heart failure.
Heart failure (HF) is complex clinical symptoms of lesion of myocardial structure and function, caused by myocardial infarction, cardiomyopathy, hypertension, inflammation and so on. The main manifestations are dyspnea, weakness and fluid retention, eventually leading to lowering the ventricular pumping and filling function. N-terminal pro B-type natriuretic peptide (NT-proBNP) and B-type natriuretic peptide (BNP) are recommended indicators of heart failure.
